Related Experiment Video
Updated: Jan 12, 2026
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
A paradigm shift in DENV-4 clinical presentation: A viewpoint on pulmonary inflammatory symptoms from the 2023
Bo Zhang1, Fuying Guo2, Peng Wang3
1School of Environmental Science and Engineering, Hainan University, Haikou, China.
Background:
During the 2023 outbreak of dengue virus serotype 4 (DENV-4) in Lincang, China, we noted prominent lower-respiratory involvement not typically emphasized in dengue descriptions.
Methods:
We retrospectively analyzed 147 hospitalized, RT-PCR-confirmed DENV-4 cases. Respiratory assessment followed a tiered protocol: daily symptom screening and pulse oximetry for all patients; chest radiography and point-of-care lung ultrasound as indicated; and chest CT for severe or atypical presentations. Symptom structure was evaluated using EBICglasso network analysis. Predictors of severe dengue were examined with logistic regression.
Results:
Pulmonary symptoms occurred in 31.3% (46/147), most frequently lower respiratory infection (28.6%), cough (25.9%), and chest distress (15.0%). Symptoms resolved quickly with supportive care (median 7 days, IQR 6-9), with no residual pulmonary sequelae at discharge. Network analysis identified a cohesive respiratory cluster with regularized partial correlations of 0.19-0.23, indicating robust conditional associations among pulmonary symptoms within the overall clinical spectrum. In regression models, thrombocytopenia (Adjusted Odds Ratio, AOR 3.06, 95% CI 1.05-9.03) and hepatic hypofunction (AOR 3.82, 95% CI 1.00-13.61) were independently associated with severe dengue; coexisting lower respiratory infection was associated with severity in univariate analysis (Odds Ratio, OR 2.91, 95% CI 1.05-8.07). Sex-specific patterns emerged: females more often had weakness, leukopenia, headache, and hypokalemia, whereas males had higher rates of hyperuricemia.
Conclusions:
In this genotype I DENV-4 cohort, lower-respiratory manifestations were common, formed a coherent symptom network, and showed signals of association with severity. These findings support routine respiratory screening, pulse oximetry, and stepwise imaging in dengue care pathways, with validation needed in multicenter studies.
More Related Videos
04:03Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:29Pneumonia II: Pathophysiology
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:28Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History